Project MB5029 selected as National New Drug Development Project Date2024-11-25 View321 https://www.biospectator.com/news/news_print?varAtcId=23667 Prev MUSTBIO Presents Promising Preclinical Data on its αPD-1/IL-2v at SITC 2024 (Biospectator, 2024.11.14) Next MustBio Selected for J&J JLABS Korea Program back to list
